Tevogen Bio Holdings (TVGN) Current Taxes (2021 - 2023)
Tevogen Bio Holdings (TVGN) reported Current Taxes of $182000.0 for Q1 2023, up 264.0% on a YoY basis from $50000.0 in Q1 2022, and up 30.0% quarter-over-quarter from $140000.0 in Q4 2022.
Tevogen Bio Holdings (TVGN) Current Taxes (2021 - 2023) Analysis & Trends
Tevogen Bio Holdings has reported Current Taxes for 3 years, with the latest figure at $182000.0 in Q1 2023.
- For the quarter ending Q1 2023, Current Taxes rose 264.0% year-over-year to $182000.0; the trailing twelve-month figure through Mar 2023 stood at $182000.0 (up 264.0% YoY), and the FY2022 full-year result was $140000.0, up 600.0% from the prior year.
- Current Taxes for Q1 2023 stood at $182000.0, up from $140000.0 in the prior quarter.
- The five-year high for Current Taxes was $182000.0 in Q1 2023, with the low at $20000.0 in Q4 2021.
- Historically, Current Taxes has averaged $97000.0 across 3 years, with a median of $95000.0 in 2022.
- Annual changes were most pronounced in 2022 — Current Taxes surged 600.0% — and 2023, when it soared 264.0%.
- Tevogen Bio Holdings' Current Taxes stood at $20000.0 in 2021, then surged by 600.0% to $140000.0 in 2022, then increased by 30.0% to $182000.0 in 2023.
- The last three Current Taxes figures came in at $182000.0 (Q1 2023), $140000.0 (Q4 2022), and $110000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 10,460.56 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 20,000.00 |